Description
DECREASE FUNDING DIASORIN REAGENTS AND LIAISON XL ANALYZERS
Base award description: DIASORIN REAGENTS AND LIAISON XL ANALYZERS ORDERING PERIOD 5.
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-01+$480,000= $480,000
- Mod P000012024-12-19-$203,238= $276,762
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-01 | +$480,000 | $480,000 | DIASORIN REAGENTS AND LIAISON XL ANALYZERS ORDERING PERIOD 5. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-19 | −$203,238 | $276,762 | DECREASE FUNDING DIASORIN REAGENTS AND LIAISON XL ANALYZERS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FGK2QR959BV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0641 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $172,138 | FY2026 |
| 36C24426A0041 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36C24426N0964 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $45,218 | FY2026 |
| 36C24426N0963 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $244,586 | FY2026 |
| 36C26026N0382 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q301 · REFERENCE LABORATORY TESTING | $125,000 | FY2026 |
| 36C24426N0738 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $78,181 | FY2026 |
Other recipients under 6630 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926F0180 | MOUNTAIN HORSE LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $90,836 | FY2026 |
| 36C24926N0390 | BECKMAN COULTER, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $42,481 | FY2026 |
| 36C24926F0025 | SIEMENS INDUSTRY INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $71,144 | FY2026 |
| 36C24926N0003 | BECKMAN COULTER, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $198,973 | FY2026 |
| 36C24926N0065 | BECKMAN COULTER, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $46,261 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24924N0062_3600_36C24920D0057_3600 · retrieved 2026-09-26.